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Abstract
Background: Membrane proteins (MPs) play key roles in signal transduction. However, understanding their function at a
molecular level is mostly hampered by the lack of protein in suitable amount and quality. Despite impressive developments
in the expression of prokaryotic MPs, eukaryotic MP production has lagged behind and there is a need for new expression
strategies. In a pilot study, we produced a Drosophila glutamate receptor specifically in the eyes of transgenic flies,
exploiting the naturally abundant membrane stacks in the photoreceptor cells (PRCs). Now we address the question
whether the PRCs also process different classes of medically relevant target MPs which were so far notoriously difficult to
handle with conventional expression strategies.
Principal Findings: We describe the homologous and heterologous expression of 10 different targets from the three major
MP classes - G protein-coupled receptors (GPCRs), transporters and channels in Drosophila eyes. PRCs offered an
extraordinary capacity to produce, fold and accommodate massive amounts of MPs. The expression of some MPs reached
similar levels as the endogenous rhodopsin, indicating that the PRC membranes were almost unsaturable. Expression of
endogenous rhodopsin was not affected by the target MPs and both could coexist in the membrane stacks. Heterologous
expression levels reached about 270 to 500 pmol/mg total MP, resulting in 0.2–0.4 mg purified target MP from 1 g of fly
heads. The metabotropic glutamate receptor and human serotonin transporter - both involved in synaptic transmission -
showed native pharmacological characteristics and could be purified to homogeneity as a prerequisite for further studies.
Significance: We demonstrate expression in Drosophila PRCs as an efficient and inexpensive tool for the large scale
production of functional eukaryotic MPs. The fly eye system offers a number of advantages over conventional expression
systems and paves the way for in-depth analyses of eukaryotic MPs that have so far not been accessible to biochemical and
biophysical studies.
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Introduction
Membrane proteins (MPs) represent more than 30% of the cell
proteome [1] and play key roles in signal transduction.
Dysfunction often leads to major disorders or death and therefore,
MPs account for more than 50% of the current drug targets [2].
However, drug discovery as well as detailed biochemical and
structural studies are still hindered by a number of problems
already encountered in the production of eukaryotic MPs. It is
therefore not surprising that the majority of eukaryotic MPs found
in the structural database (Membrane Proteins of Known 3D-
Structure, http://blanco.biomol.uci.edu) are naturally abundant
[3,4] and that their structures were determined using material
from wild-type organisms. Most of them are localized in
specialized cells from i.e. the retina for rhodopsin, the lens for
aquaporins, the sarcoplasmic reticulum for calcium ATPases and
the electric organ of Torpedo for the nicotinic acetylcholine
receptor pore. These cells are adapted to the massive production
of MPs, which are often densely packed in their respective
membrane environment.
In contrast to eukaryotic MPs, our understanding of prokaryotic
MPs has tremendously increased in the past decade due to the
optimization of bacterial strains and expression tools for MP
production [4], as well as by the use of extremophilic organisms
(e.g. Archaea) as a source for MPs of increased stability [5].
Bacteria enriched in membranes are widely used for MP
expression as they seem to offer increased membrane surface as
well as an optimized insertion machinery [6]. The crystal
structures of close prokaryotic homologs provided relevant models
for many mammalian MPs. However, some eukaryotic MPs which
are of prime interest in neuropharmacology, like the sodium-
dependent serotonin transporter (SERT or 5HTT), do not have
close bacterial homologs [7]. Importantly, differences in the active
sites have been observed e.g. in rhodopsin [8] or potassium
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precise architecture of these binding sites can be difficult to model
which leads to controversies in the perception of their reaction
mechanisms. For MPs regulated by allosteric mechanisms [10],
focusing on the ligand binding site is not sufficient. Among G
protein-coupled receptors (GPCRs), metabotropic glutamate
receptors (mGluRs) are prototypes for allosteric regulation and
have been subjected to random high-troughput ligand screens for
drug design as well as structure-based virtual screening [11,12].
Both, high-throughput pharmacological and structural analyses of
MPs require amounts of material which are often not provided in
sufficient quality and quantity by conventional expression systems.
Eukaryotic cells in culture, like insect cells and yeast are
commonly used for the overexpression of eukaryotic MPs [3].
However, a major drawback is the often limited capacity of these
cells for trafficking, folding and membrane insertion of the target
MPs and therefore, a significant portion of immature MPs remain
trapped in internal membranes [13]. In a pilot study, we
engineered a transgenic fly overexpressing a recombinant
Drosophila metabotropic glutamate receptor (DmGluRA) specifi-
cally in the eyes [14]. The idea was to target the receptor to the
naturally abundant membrane stacks in the photoreceptor cells
(PRCs), the rhabdomeres, housing the GPCR-prototype rhodop-
sin. Drosophila melanogaster was chosen because fly genetics offers the
possibility of regulating ectopic expression in intensity, kinetics and
localization using specific promoters (drivers). The DmGluRA
production in fly eyes gave higher yields than the baculovirus
overexpression system in Sf9 cells and the receptor was functional.
In addition, the purified protein was clearly superior in
homogeneity compared to protein obtained from Sf9 membranes
[14] which typically suffers from the presence of immature
receptors [3]. The receptor could be purified in mg amounts [14]
and biochemical analysis suggested cholesterol as an allosteric
regulator that switches the receptor to a high affinity state [15].
Recently, the expression protocol was improved by the use of
GFP-fusion constructs [16]. However, the question remained
whether overexpression in fly eyes would be also applicable to the
heterologous expression for MPs like transporters and channels
which are often difficult to express in conventional systems.
In this study, we show the exceptional properties of the PRCs in
offering seemingly unsaturable membrane space for target MP
insertion. We describe the heterologous expression of functional
MPs including mammalian GPCRs, neurotransmitter transporters
and the channelrhodopsin ChR2. We establish overexpression in
fly eyes as a general, efficient and inexpensive method for large
scale production of functional eukaryotic MPs and exemplify our
findings with an in depth analysis of mGluR5 and SERT.
Results
Photoreceptor cells have a large capacity for
recombinant MPs
The successful expression of a functional Drosophila metabotro-
pic glutamate receptor DmGluRA in fly eyes recommended this
system for the production of eukaryotic MPs [14] (see Supporting
Information: Primer of the fly eye system (Primer S1)). We now
addressed the question whether overexpression in the eyes is
superior to overexpression e.g. in the whole fly or other body parts.
DmGluRA was expressed in transgenic flies under the control of
different drivers [17] inducing specific expression in the eyes
(GMR- or Rh1-GAL4) or ubiquitous expression (Tubulin-, Actin-
or Armadillo-GAL4). The expression driven by eye-specific
promoters was impressive compared to the insignificant levels
obtained with ubiquitous promoters (Figure 1A). Using an eye-
specific driver was a prerequisite for high expression.
The green fluorescent protein (GFP) was fused to the C-
terminus of all MP-targets in this study for efficient monitoring
[18], e.g. to select the best expressing flies, for quantification,
localization of expression and for quality control of large-scale
cultures. GFP fluorescence indicates also correct folding of the N-
terminally fused partner protein [19]. Flies expressing different
GPCR-GFP fusion constructs under the control of GMR-GAL4
were generated (for technical details see [16]). Quantification by
fluorescence-scanning of native gels (Figure 1B) showed that e.g.
DmGluRA expression levels reached about 50% of endogenous
rhodopsin (Rh1) present in the PRCs (Table 1). Recombinant Rh1
could be expressed at similar levels (502 pmol/mg MP or 18 ng/
eye) as endogenous Rh1 (3 to 6610
7 Rh1 molecules/rhabdomere,
corresponding to 10 to 20 ng/eye [20,21]) and similar to
recombinant Rh1 not fused to GFP (15 ng/eye [22]) (Table 1).
A number of rhodopsin-type GPCRs (Class A GPCRs [23]) were
tested for heterologous expression. Among them, the mammalian
Figure 1. Recombinant expression of Drosophila and mammalian GPCRs in fly eyes. (A). Western blot analysis of DmGluRA expression
using eye-specific (GMR, Rh1) or ubiquitous (Armadillo, Actin, Tubulin) promoter elements. DmGluRA was detected with the 7G11 antibody. b-tubulin
was used as a loading control (not shown). (B). Quantification of DmGluRA-GFP expressed under the control of the GMR driver. Intrinsic fluorescence
signal of DmGluRA-GFP (1) compared with the GMR driver fly (2)(lower inset). The heads of three flies were analyzed. The GFP standard curve shown
as graph was obtained by fluorescence scanning of a clear-native gel (using 5, 10, 25, 50, 75 ng GFP; upper inset). Fluorescence signals were
integrated with the ImageJ software. (C). Typical fluorescence image of a transgenic Drosophila expressing the human vasopressin receptor V2R-GFP
under the control of the eye-specific GMR
1104 driver. The inset shows the fluorescence signals of V2R-GFP (3) and Rh1-GFP (4) from three fly heads.
doi:10.1371/journal.pone.0018478.g001
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cases (.1 mmol/mg MP; Table 1, Figure 1C). V2R is involved in
the regulation of water homeostasis by the kidney and in X-linked
nephrogenic diabetes insipidus [24]. The expression level of V2R
in PRCs is higher than the best ones previously reported using
conventional overexpression systems optimized for eukaryotic MPs
[4,25]. Human CCR5, a chemokine receptor currently serving as
a major therapeutic target against HIV cell-entrance [26], was
expressed at levels similar to Drosophila Rh1 (555 pmol/mg MP;
Table 1). These examples suggest that heterologous expression in
the fly eye can be applied to most class A GPCRs. Since fly Rh1 is
the predominant MP in rhabdomere membranes [27], it is
remarkable that the overexpression of recombinant MPs did not
affect the amount of endogenous Rh1 as analyzed by Western blot
(not shown). On the other hand, the high level of endogenous Rh1
does not seem to limit the expression of recombinant MPs. The
rhabdomere membranes appear to have seemingly unsaturable
capacity to accommodate MPs.
A rhodopsin knock-down is not required for high
expression levels
The capacity of the PRCs to host large amounts of recombinant
MPs in the presence of endogenous Rh1 indicates that there is no
need to down-regulate Rh1inorder toincrease theexpression levels.
In contrary, a fly knock-out for Rh1 would alter the biogenesis of the
rhabdomere membrane [28,29]. Moreover, the expression of algal
channelrhodopsin ChR2 which contains retinal as a cofactor [30]
was shown to directly correlate with the levels of endogenous Rh1
(Figure 2). Chlamydomonas reinhardtii ChR2 was expressed under the
control of different drivers including GMR drivers of diverse origins.
Briefly, the use of a GMR driver (Bloomington #1104) [31]
constructed on a gl
60j genetic background missing the glass protein
[32] and therefore Rh1 [33] gave a surprisingly strong eye-
phenotype (Figure 2A) not seen i.e. for V2R-expressing flies (not
shown), and ChR2 was barely detectable (Figure 2B, lane 1). Two
other GMR drivers (Bloomington #9146 and #8605) expressing
higher amounts of Rh1 (Figure 2B, lane 2 and 3, respectively)
induced also a higher expression of ChR2 (Figure 2B, lanes 2 and 3,
respectively). A correlation with Rh1 levels was not observed for
other MPs targets e.g. the V2R (not shown). Therefore, expression of
Rh1 and ChR2 are somehow linked. ChR2 expression reached
200 pmol/mg MP (Table 1). In the presence of Rh1, the channel
localized in the rhabdomeres (Figure 2C) and the eye morphology
was normal (Figure 2C, Inset). The observed retinal (Figure S1A)
and Rh1 dependence for the proper processing of recombinant
ChR2 indicated that thephotoreceptorcellsarespeciallyadaptedfor
the expression of retinal-binding membrane proteins.
Heterologous and homologous expression of glutamate
receptors give similar amounts
We have shown that GPCRs canbe expressed inhigh amounts in
the fly eyes. In order to compare heterologous and homologous
expression we choose mGluRs. Mammalian mGluR5 is involved in
antipsychotic medication and subject of intensive pharmacological
and structural characterization [34,35]. Expression of mGluR5
gave strong eye fluorescence (not shown) with expression levels
similar to DmGluRA according to Western blot and fluorescence-
scanning analyses (Figure 3A; Table 1).For functional tests flyheads
were collected as previously described [16] and membranes were
prepared for radioactive glutamate binding assays. mGluR5 had an
affinity for glutamate (3162 mM) (Figure 3B) in the same range as
reported previously for DmGluRA (54 mM) [15] suggesting proper
foldingofthe heterologously expressedreceptor.The results showed
that heterologous expression of functional GPCRs was efficient and
reached similar levels as homologous expression.
Heterologous expression of neurotransmitter
transporters
Encouraged by the success with heterologous expression of
GPCRs and channelrhodopsin ChR2, we set out to test the fly eye
system also for membrane transporters. For eukaryotic neurotrans-
mitter transporters low level expression and heterogeneity have
been reported from classical overexpression systems. The serotonin
transporter (SERT) seems to require rather sophisticated overex-
pression systems i.e. with engineered chaperones [36]. We tested
serotonin transporters from human (HsSERT) and Drosophila
(DmSERT). Strong expression was detected by epifluorescence
microscopy and by Western blot analysis for HsSERT (Figure 3C).
DmSERT and HsSERT expression quantified by fluorescence
scanning of native gels was 493 and 220 pmol/mg MP, respectively
(corresponding to 43 and 20 ng SERT/eye, respectively; Table 1).
These expression levels are in range with endogenous rhodopsin.
Proper folding of HsSERT is indicated by binding the inhibitors
R,S-citalopram (nanomolar affinity; Figure 3D) and cocaine
(309638 nM, not shown) with similar affinities as reported
previously [37,38]. Similarly, the glutamate transporters DmEAAT1
and HsEAAT2 both expressed well in fly eyes (Table 1). These data
show that the fly eye system is suitable for heterologous and
homologous expression of functional neurotransmitter transporters.
SERT and Rh1 localize in distinct domains in the
rhabdomere membrane
We have shown that despite the high quantities of endogenous
Rh1, SERT is expressed in similarly high amounts. In order to test
whether HsSERT and Rh1 co-localize in the PRCs, HsSERT
localization was analyzed by 3D-laser-scanning confocal micros-
Table 1. Expression levels of target MPs.
Target MP_ Species
Expression
level [pmol/mg
total MP]
GPCRs (7 TMs)
Endogenous Rh1_Drosophila rhodopsin 272–544*
Rh1_Drosophila rhodopsin 502
V2R_Human vasopressin receptor .1000
CCR5_Human chemokine receptor 555
DmGluRA_Drosophila metabotropic glutamate
receptor
226
mGluR5_Rat metabotropic glutamate
receptor
192
Channel (7 TMs)
ChR2**_Clamydomonas channelrhodopsin 206
Transporters (12TMs)
SERT_Drosophila serotonin transporter 493
SERT_Human serotonin transporter 220
EAAT2_Human glutamate transporter 173
EAAT1_Drosophila glutamate transporter 716
*Endogenous Rh1 rhodopsin levels are 3 to 6610
7 Rh1 molecules/rhabdomere
[20,21] corresponding to 272 to 544 pmol/mg total MP.
**MPs were expressed under the control of the GMR
1104 driver except for ChR2
(GMR
9146).
doi:10.1371/journal.pone.0018478.t001
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fly expressing ChR2-GFP under the control of the GMR
1104 driver (Inset: bright light picture of the head). (B). ChR2-GFP expression driven by different
GMR promoter elements (GMR
1104 (1), GMR
9146 (2), and GMR
8605 (3)) analyzed by Western blot and compared with endogenous Rh1 levels. ChR2-GFP,
Rh1 and b-tubulin were detected with GFP, Rh1 and b-tubulin antibodies, respectively. (C). Analysis of an intact head using a water-immersion
objective shows rhabdomere localization of ChR2-GFP expressed under the control of GMR
9146. Magnification was 10620. Inset: the bright light
picture shows normal eye morphology. For easier recognition, the facettes of the fly eye are marked by hexagons.
doi:10.1371/journal.pone.0018478.g002
Figure 3. Heterologous expression of functional GPCRs and transporters in fly eyes. (A). Western blot analysis of Drosophila (DmGluRA-
GFP) or mammalian (mGluR5-GFP) metabotropic glutamate receptors expressed in fly eyes using a GFP antibody. The GMR driver fly is shown as a
negative control. (B). Homologous competitive binding experiment with glutamate [15] on membranes from flies expressing mGluR5-GFP. (C).
Western blot analysis of the human serotonin transporter HsSERT-GFP expressed in fly eyes using a GFP antibody. The GMR driver fly and GFP
standard are shown as negative and positive controls, respectively. (D). Competition binding experiment on membranes from flies expressing
HsSERT-GFP. Binding of [
125I]-RTI55 was competed with racemic citalopram (Ki 4.562.7 nM). (E). Three-dimensional reconstruction from laser
scanning confocal microscopy images of a fly eye expressing HsSERT-GFP. GFP fluorescent signal, showing the presence of HsSERT in all rhabdomeres
of all ommatidia (in green); natural autofluorescence delimits the surface of the eyes (in blue). The scale bar represents 40 mm. Inset: Analysis of an
intact head using a water-immersion objective shows rhabdomere localization of HsSERT-GFP expressed under the control of GMR
1104. Magnification
was 10620. (F–G). EM-double immunogold labeling of recombinant HsSERT-GFP and endogenous Rh1 with the GFP (10 nm gold) and the Rh1
(15 nm gold) antibodies, respectively, using purified rhabdomere membranes. (F). Typical Rh1-positive domain. (G). Typical HsSERT-labeled domain.
(H). Coomassie-stained SDS-PAGE of HsSERT-GFP purified [52] in one step using a nickel column (lane 2). MW standards are shown in lane 1.
doi:10.1371/journal.pone.0018478.g003
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epifluorescence microscopy using water-immersion objectives [39]
(Figure 3E,inset). HsSERT is expressed in all 7 rhabdomeres of
each compound eye called ommatidia. The distribution of
HsSERT (Figure 3E) and DmSERT (not shown) in the
rhabdomeres is similar to rhodopsins [29,40]. However, it was
possible to separate domains containing endogenous Rh1 from
those containing DmSERT using an Ultra-Turrax for membrane
disruption and subsequent ultracentrifugation in a density gradient
(Figure S3). This suggests that Rh1 and DmSERT are accommo-
dated in separate membrane areas of the rhabdomeres. To further
investigate this, electron microscopy with double gold-immunola-
beling using anti-Rh1- and anti-GFP antibodies was performed on
rhabdomere membranes (Figure 3F–G). 56% and 42% of the
membrane structures were either positive for Rh1 (Figure 3F) or
SERT-GFP (Figure 3G) respectively, and only 2% contained a
Rh1/SERT-GFP mixture. Therefore, Rh1 and DmSERT indeed
localize in separate membrane domains. This shows the feasibility
of further analysis of the supramolecular organization of SERT
and probably other recombinant proteins in rhabdomere mem-
branes by biophysical methods like cryo-electron microscopy [41]
or atomic force microscopy [42,43].
Large-scale purification of MP targets
Some overexpression systems like Pichia pastoris display often
impressive levels of MP production at a small scale but expression
at a larger scale is tricky and requires sophisticated devices [44]. In
order to test the scalability of the fly eye system, the fly cultures
were expanded (Figure S2) and HsSERT was subjected to large
scale purification. Fly heads were collected for membrane
preparation [16]. A volume of 4 ml (2 g) frozen fly heads gave
typically 45 mg of total MP with 0.5 mg HsSERT (1 mg
DmSERT) purified routinely using an affinity column
(Figure 3H). The transporters and receptors are now used for
detergent optimization and crystallization trials. Taken together,
the amounts obtained with the fly eye system in combination with
the superior homogeneity of the protein provide the basis for
further biochemical, pharmacological and structural analyses.
Discussion
We show that the expression of eukaryotic membrane proteins
in the eye of transgenic Drosophila is a powerful tool for the
production of functional GPCRs, neurotransmitter transporters
and channels. For SERT we demonstrate that the fly eye system
can be scaled up to the amounts needed for routine crystallization
studies and biochemical characterization. The expression levels of
a number of test cases come close to that of endogenous rhodopsin.
Using a GFP tag for monitoring allows for easy in vivo and in vitro
MP analysis and quality control of the fly cultures.
Specific properties of the fly eye system offer major advantages
compared to conventional expression systems. These include
accessibility, low cost and superior quality of the expressed
proteins [14,45]. The PRCs maintain a high turnover of rhodopsin
in their specialized membrane stacks [21,46] which relies on high-
throughput MP production, folding and targeting. Being special-
ized and polarized cells, PRCs [47,48] harbor the rhabdomeres as
an ideal storage compartment for MPs. PRC targeting of MPs that
are often toxic for the host cell might benefit from the absence of
endogenous ligand or from having only minor effects on local
metabolism. We observed that the capacity of the PRCs to host
MPs seems almost unsaturable, as in addition to endogenous
rhodopsin equivalent amounts of recombinant MP can be
accommodated. Heterologous expression can reach a similar level
as homologous expression as shown for the mammalian mGluRs
and SERT. The fly eye system is therefore particularly suited for
heterologous expression.
In conventional eukaryotic expression systems ER retention of
recombinant GPCRs and transporters can indicate improper
folding and is often a problem e.g. for expression in yeast. In the fly
eye system the majority of the target proteins were localized
entirely in rhabdomere membranes. This also demonstrates that
MPs with various intrinsic signal sequences are targeted to the
rhabdomeres. The expression of the channelrhodopsin ChR2 was
dependent on the endogenous Rh1 levels, suggesting a co-
transport to the rhabdomeres. Also, there is indication that
ChR2 expressed in PRCs binds its cofactor retinal, necessary for
folding and activity. In addition to the classical post-translational
modifications like glycosylation [49], the PRCs can efficiently
produce retinal-binding proteins, while classical eukaryotic cell
cultures or cell-free expression systems would require an
exogenous supply of cofactor [50,51].
Expression of MPs in the fly eye system is also a cheap
alternative to expensive eukaryotic cell cultures and their
requirement to work sterile. The costs for making a transgenic
fly (e.g. through collaboration or using a Drosophila injection
service) and maintaining even large scale cultures is negligible
(Note: the food being made of cornmeal, moult, yeast and sugar is
inexpensive with only around 10$/40 large vials). In addition,
making a fly can be faster than producing baculovirus stocks for
overexpression in insect cells. Due to the short life cycle of the flies,
about one month is sufficient starting from the DNA-construct of
the target MP to the first expression test with the transgenic fly.
While an overall comparison of different expression systems is
straightforward concerning the costs, the comparison of yields,
workload and most importantly the protein quality requires more
attention. Compared with expression systems that require liters of
sterile medium, the continuous fly cultures and the handling of
small volumes (125 ml of flies corresponding to 25 kflies or $1m g
of pure target MP) provide important advantages. When the
workload of membrane preparation and the quality of the purified
MPs are compared with conventional expression systems, the fly
eye system is superior.
Taken together, we developed a fly eye system for the
heterologous and homologous expression of different classes of
eukaryotic membrane proteins. It offers a number of advantages
compared to conventional expression systems and is more easily
accessible than one would probably imagine. The fly eye system
opens the door for studying eukaryotic membrane proteins that
have so far not been accessible to biochemical and biophysical
studies.
Materials and Methods
Cloning strategy
MP targets: the rat mGluR5 (mGluR5), human sodium-
dependent serotonin transporter (HsSERT), glutamate transport-
ers (EAATs) and channelrhodopsin (ChR2) constructs were
generous gifts from J.-P. Pin (Montpellier, France), R. D. Blakely
(Nashville, USA), S. Birman (Marseille, France) and P. Hegemann
(Berlin, Germany), respectively. The Drosophila melanogaster
SERT (DmSERT) cDNA from the Berkeley Drosophila Genome
Project was provided by BioCat/Open Biosystems (Heidelberg,
Germany).
The general protocol for cloning of target MPs has been
described previously [16]. Typically, the gene coding for the target
MP was amplified using EcoRI and a XhoI restriction sites and
cloned in frame with eGFP (GFP) into the Drosophila pUAST
Eukaryotic Membrane Protein Expression
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linker encoded by the XhoI site followed by the TEV-cleavage site
ENLYFQG and at the C-terminus by a 6-his tag (TEV-GFP-6his).
The construct in pUAST was sequenced and tested for expression
in Schneider S2 cells as described [16].
Transgenic fly generation
The MP-GFP construct cloned in the pUAST vector was used
for classical P-element-mediated transformation of embryos [53] of
the Drosophila host line w
1118 (carried out by Vanedis (Oslo,
Norway) or BestGene (Chino Hills, U.S.A.)). Most of the driver
lines were provided by the Bloomington center. The various driver
lines used in this study were eye-specific using either the minimal
rhodopsin promoter for the Rh1-GAL4 line or a glass-binding
enhancer element GMR (Glass Multiple Reporter or Glass
Minimum Response) for the GMR-GAL4 lines [33,54]. The
GMR driver lines used a pentameric arrangement of an enhancer
region of the Rh1 promoter (glass binding site). The GMR
8506
driver (Bloomington #8506) has a longer pentameric repeat
(38 bp, ‘‘long GMR’’ driver) [55] than the GMR
1104 driver
(29 bp, ‘‘short GMR’’ driver) [31]. An advantage of the GMR
8506
driver is that the longer enhancer site sequence confers a strict
PRC specificity [31]. The ELAV-GAL4 driver (Bloomington
#8765) was chosen for its predominant induction of expression in
neurons [56].
Flies were reared at room temperature on standard fly food
(yeast, corn syrup and agar) in a 12 hours light/12 hours dark
cycle and stocks were kept at 18uC and 60% humidity. For scaling-
up the fly cultures, we opted for a continuous culture in vials at
room temperature instead of large cages that are difficult to handle
for fly harvesting (Figure S2). For retinal depletion experiments,
flies were reared for minimum two generations on carotenoid-free
medium (10% yeast, 10% sucrose, 0.02% cholesterol, 2% agar)
[57]. Replenishment with retinal was performed by adding 80 mg
all trans-retinal on the surface of the carotenoid-free medium [49].
Fluorescence microscopy on fly heads
For selection and sorting according to GFP fluorescence, flies
were kept anaesthetized under CO2 on a glass filter (Neolab) and
observed using a MZ 12-5 Leica stereomicroscope mounted with a
106 objective and equipped with an epifluorescence device
(illumination path: BP 480/40 nm, dichroic mirror/reflector:
505 nm, observation path: LP 510 nm).
For rhabdomere localization experiments, flies were put asleep
in CO2 and over-anaesthetized for 10 min in diethylether vapors,
mounted on a needle and observed under water using a water-
immersion objective [39] (HCX APO, L 206/0.5 W or L 406/
0.80 W U-V-I, Leica, Germany) on a DM LFS microscope (Leica,
light source: ebq 100 dc-1 [100 W], Jena GmbH, Germany; I3
filter set (illumination path: BP 450–490 nm, dichroic mirror/
reflector: 510 nm, observation path: LP 515 nm)). The fluores-
cence was documented with a digital camera (DC200, Leica,
Germany). Confocal laser scanning microscopy was performed on
intact heads mounted in PBS between two coverslips spaced by
clay on the stage of a Nikon TE2000-E inverted fluorescence
microscope. Heads were subjected to series scan (300 z-stacks) with
a 488 nm laser over half a mm depth to build a 3D-image of a
whole eye.
Harvesting of fly heads
10 ml frozen flies in liquid nitrogen were gently shaken in a
50 ml-Falcon tube together with 5 ml of glass beads (diameter
4 mm) as described [16]. Briefly, the flies and beads were
transferred on a set of sieves with decreasing meshes (Neolab
#6-2380 (the three smaller meshes)) pre-cooled in liquid nitrogen.
After shaking, the heads were collected from the middle
compartment and stored at 280uC.
Membrane preparation
Frozen fly heads were homogenized in sucrose buffer (TRIS-
HCl 50 mM, NaCl 150 mM, MgCl2 2 mM, EGTA 1 mM,
Sucrose 250 mM, pH 7.4) and membranes were prepared as
described [16]. It is noteworthy that fly eye tissue is much easier to
homogenize than cells in culture.
Western blot analysis and quantification by fluorescence
For Western Blot, 12 ml of a sample containing 5 fly heads
homogenized in 30 ml of a classical loading buffer were analyzed
and detection was performed by classical enhanced chemilumi-
nescence (ECL
TM, GE Healthcare) using an antibody against GFP
(Biovision, Mountain View), Rh1 (4C5 ascites, DSHB, Iowa), b-
tubulin (E7, DSHB, Iowa) or the Drosophila glutamate receptor
(monoclonal 7G11 [45]).
Quantification of the fluorescent recombinant proteins was
done in native gradient (4–10%)-polyacrylamide gel electropho-
resis in the presence of n-Dodecyl-b-D-maltoside (DDM) or
digitonin 0.1% in the gel [58]. Six fly heads were homogenized in
8 ml sucrose buffer complemented with the protease inhibitors (see
membrane preparation). DDM or digitonin was added (final
concentration 1%) for solubilization and left on ice for two hours.
The samples were ultracentrifuged at 4uC for 10 min and 3 ml
supernatant was mixed with 3 ml native loading buffer (TRIS-HCl
100 mM, glycerol 20%, Bromophenol blue). The samples were
loaded in parallel with a GFP standard curve (eGFP, Biovision,
Mountain View) and run at 180 V in the dark for about three
hours. The gel was analyzed using the Ettan DIGE imager (GE
Healthcare). Image J software was used to integrate the pixel
values.
Ligand binding
2.5 mg Drosophila head membranes [14] from flies expressing
HsSERT were incubated in 100 ml sodium phosphate buffer
50 mM, NaCl 100 mM, BSA 0.2% (pH 7.2) with [
125I]-RTI-55
(Perkin Elmer) and increasing concentrations of racemic citalo-
pram (Sigma) or cocaine (Sigma). Bound and free were separated
by rapid filtration on a GF/B glass filter saturated with BSA 1%
and polyethylene imine 0.5% using a Brandel M-48 harvester.
GraphPad Prism 4.0 software was used for curve fitting and data
analysis.
Preparation of rhabdomere membranes
The eyes from 50 flies expressing HsSERT were dissected and
retina membranes were released using a reciprocating shaker
(Mini-Bead-Beater, GlenMills, New Jersey) in the presence of
0.1 mm zirconia/silica beads (50 mg) in 125 ml ice-cold Optiprep
10%, HEPES-NaOH 10 mM, NaCl 120 mM, KCl 4 mM,
sucrose 32 mM, pH 7,4 buffer. The resulting membranes were
collected in the 35% Optiprep-fraction of an Optiprep-gradient
(10 to 55%) after centrifugation 2.5 h at 20,000 g, 20uC. The
presence of both rhodopsin and HsSERT in this fraction was
confirmed by Western Blot using the monoclonal 4C5 and the
GFP antibody, respectively (not shown). Alternatively, the use of
an ULTRA-TURRAX disperser instead of the Mini-Bead-Beater
produced smaller membranes containing separated Rh1- and
HsSERT rhabdomere membrane sub-populations that could be
recovered on a 40% and 20% Optiprep-gradient fraction,
respectively (Figure S3).
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Membranes resuspended in Ringer buffer at 0.1 mg/ml were
adsorbed on 300-mesh carbon-coated EM grids (EM Sciences,
Munich, Germany) for 2 min at RT. For immunogold labeling of
GFP fusion proteins, unspecific labeling was blocked by incubating
the grids on blocking solution (0.8% bovine serum albumin, 0.1%
fish skin gelatin in PBS) for 10 min at RT. The samples were then
double-labeled according to Slot et al. [59] except that the
antibody and protein A incubation times were reduced to 15 and
10 min, respectively. The antibody against GFP (Molecular
Probes, dil. 1/200) was used first followed by rhodopsin antibody
(4C5, DSHB Iowa, dil. 1/1000) and rabbit anti-mouse (DaKo-
Cytomation, Denmark). After the last incubation with protein A
coupled to gold (University of Utrecht, the Netherlands), the grids
were washed 5 times in PBS, 5 times in water and the samples
were embedded by looping out the grids in a mixture of 8 parts
methyl cellulose (Sigma, 25 centipoise; 2%) and 2 parts uranyl
acetate (Fluka, Heidelberg, Germany, 3% in water) and removing
excess liquid on a filter. Grids were analyzed with a Zeiss electron
microscope EM10 and images taken with a Gatan MultiScan
TM
camera and Digital Micrograph
TM software and further processed
using Adobe Photoshop CS3.
Additional methods
Additional information on large scale fly cultures is available in
Figure S2.
Supporting Information
Figure S1 ChR2 expression depends on retinal. Like
rhodopsin, ChR2 is a retinal-binding protein
1. Transgenic flies
expressing ChR2-GFP grown on carotenoid-depleted food
2, which
prevents retinal synthesis, showed a clear drop in ChR2 expression
(lane 2) compared to flies grown on normal medium (lane 1).
ChR2 expression was recovered by replenishing the food with
synthetic all-trans retinal (lane 3), indicating that the observed
effect is specific for retinal. Lane 4 shows a driver fly as a control.
A Western blot using a GFP antibody with two fly heads is shown.
The same blot was analyzed with antibodies against b-tubulin as a
control of protein load and against Rh1, respectively. The well-
known dependence on retinal is observed for endogenous Rh1
expression
3. The requirement of the chromophore for ChR2
expression could be a prerequisite for folding or could indicate that
it follows the endogenous Rh1 levels.
(DOC)
Figure S2 Large scale Drosophila cultures. 1. Initial
cultures: 12 crosses (in 12 vials) were made between the UAS-
MP-GFP fly line and the driver line in small 2,5 cm-diameter vials
(10 ml fly food). Alternatively, a stable expressing line GMR-
GAL4;UAS-MP-GFP can be used (described in
4). 2. Egg-laying
Flies: the offspring was collected into larger vials (35 ml fly food)
i.e. flies from 4 small vials transferred in one large vial with 5 cm
diameter. Those flies of the first generation were used to lay eggs in
large vials and were passed every fourth day in new large 5 cm-
diameter vials. 3. Harvesting Tour: the vials emptied of flies and
full of larvae were used for the fly harvesting. The whole culture
consisted of 12 small vials (first generation flies), around twelve
larger vials used for laying eggs (first generation flies) and three
racks each containing 40 large harvesting-vials (third and fourth
generation flies). The time required to scale-up the culture for MP
purification in milligram amounts is about one month and the
culture is kept running continuously. Harvesting by flushing CO2
into the 3640 vials to anaesthetize the flies and freeze them in
liquid nitrogen, takes about 40 min. The harvested flies were
stored at 280uC. Note: for fly harvesting vials were better than the
large cages utilized for larvae collection
5.
(DOC)
Figure S3 Endogenous Rh1 and recombinant HsSERT
localize in separate rhabdomere domains. The heads of 50
flies expressing HsSERT under the control of the GMR
1104 driver
were dispersed with an Ultra Turrax in 300 ml of a buffer
containing NaCl 120 mM, KCl 4 mM, sucrose 30 mM, Hepes-
NaOH 10 mM pH 7.4, 8% OptiprepH and protease inhibitors
(CompleteH). The resulting membranes were loaded on the top of
an Optiprep gradient (10 to 55%) in the same buffer, centrifuged
2.5 h at 20,000 g, 20uC and the fractions (1 to 8 from top to
bottom, respectively) were analyzed by Western blot with an
antibody against GFP or Rh1, respectively. The results indicate
that HsSERT, which localizes in rhabdomeres (Figure 3E),
accumulates in different membrane areas than endogenous Rh1.
HsSERT-containing membranes were less dense than Rh1
domains. This difference is most likely due to the density of the
membrane proteins packed in these areas.
(DOC)
Primer S1 Primer for MP expression in fly eyes.
(DOC)
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